Beta Bionics (BBNX) Current Assets (2023 - 2026)

Beta Bionics has disclosed Current Assets across 4 years of filings, most recently posting $248.0 million for Q1 2026.

• Current Assets for Q1 2026 came in at $248.0 million, down 5.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $248.0 million (down 5.32% YoY), and the FY2025 annual result was $267.9 million, up 101.55% from the prior year.
• Current Assets came in at $248.0 million for Q1 2026 at Beta Bionics, down from $267.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $286.1 million in Q2 2025 to a low of $103.6 million in Q4 2023.
• The 4-year median for Current Assets is $261.9 million (2025), against an average of $224.4 million.
• Across the five-year window, Current Assets soared 101.55% in 2025 and dropped 5.32% in 2026, its largest moves.
• Beta Bionics' Current Assets stood at $103.6 million in 2023, then climbed by 28.28% to $132.9 million in 2024, then jumped by 101.55% to $267.9 million in 2025, then decreased by 7.44% to $248.0 million in 2026.
• The last three Current Assets figures came in at $248.0 million (Q1 2026), $267.9 million (Q4 2025), and $270.0 million (Q3 2025), per Business Quant data.